Gargi Choudhary

Gargi Choudhary has extensive work experience in the pharmaceutical industry. Gargi is currently serving as the Vice President of Analytical Development at Vaxart Inc. Prior to that, they held the position of Head of Analytical Development and QC at Apellis Pharmaceuticals from 2019 to 2021. Before that, they worked as a Senior Director at Tricida, Inc. from 2014 to 2018. From 2011 to 2014, they served as the Director of Analytical Development and Quality Control at Relypsa. Gargi also worked at Novartis Pharmaceuticals from 2007 to 2011, initially as a Principal Scientist and later focused on the acquisition of the Inhalation Business Unit of Nektar Therapeutics. Gargi started their career as a Scientist at Thermo Electron from 2000 to 2007.

Gargi Choudhary holds a Ph.D. degree in Chemical Engineering from Yale University. Gargi also obtained a B.Tech degree in Chemical Engineering from Indian Institute of Technology, Delhi. Additionally, their education history includes studying at Sardar Patel, although the degree and field of study for this institution are not specified.